Areas of Focus
- Pathogenesis and treatment development for psychiatric and neurological disorders such as epilepsy and Parkinson's disease
Work Experience
- Current - Shanghai Jiao Tong University, Associate Professor
Academic Background & Achievements
- PhD in Neurobiology from the University of Tokyo
- Recognized as Shanghai Pujiang Talent
- Recipient of the Second Prize of Shanghai Science and Technology Progress Award
Publications
- Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease, Shengtian Li
- Protective effects of β-nicotinamide adenine dinucleotide against motor deficits and dopaminergic neuronal damage in a mouse model of Parkinson’s disease, Shengtian Li
- Osteocalcin ameliorates cognitive dysfunctions in a mouse model of Alzheimer’s Disease by reducing amyloid β burden and upregulating glycolysis in neuroglia., Shengtian Li
- Kininogen level in the cerebrospinal fluid may be a potential biomarker for predicting epileptogenesis, Shengtian Li
- Antidepressant-like Effect of Low-intensity Transcranial Ultrasound Stimulation, Shengtian Li
- Osteocalcin ameliorates motor dysfunction in a 6-hydroxydopamine hydrobromide-induced Parkinson’s disease rat model through AKT/GSK3β signaling, Shengtian Li
- PHF8 histone demethylase deficiency causes cognitive impairments through the mTOR pathway, Shengtian Li
- Nicotinamide adenine dinucleotide suppresses epileptogenesis at an early stage, Shengtian Li
- Synaptic and Extrasynaptic Glutamate Signaling in Ischemic Stroke, Shengtian Li
Awards
- 2006: Shanghai Pujiang Talent Program support
- 2019: Second Prize of Shanghai Science and Technology Progress Award
